This measure captures the proportion of ischemic stroke patients prescribed antithrombotic therapy at hospital discharge.
This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-3: Anticoagulation Therapy for Atrial Fibrillation/Flutter, STK-4: Thrombolytic Therapy,STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s hospital accreditation and Disease-Specific Care certification programs. STK-2, Discharged on Antithrombotic Therapy, is one of six of the measures in this set that have been reengineered as eCQMs and are included in the EHR Incentive Program and Hospital Inpatient Quality Reporting Program.
Measure Specs
General Information
Numerator
Patients prescribed antithrombotic therapy at hospital discharge.
Denominator
Patients with a principal diagnosis of ischemic stroke.
Exclusions
Denominator Exclusions:
Patients with comfort measures documented.
Patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.
Patients discharged to another hospital
Patients who left against medical advice
Patients who expired
Patients discharged to home for hospice care
Patients discharged to a health care facility for hospice care
Denominator Exceptions:
Patients with a documented reason for not prescribing antithrombotic therapy at discharge.
Measure Calculation
Measure Record
Point of Contact
Measure specifications are in the Public Domain
LOINC(R) is a registered trademark of the Regenstrief Institute.
This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2014 International Health Terminology Standards Development Organization. All rights reserved.
Public Comments